Stephen Bagley
Assistant Program Director, Neurocritical Care · Perelman School of Medicine at the University of Pennsylvania
Credentials: · · ·
History
- Present
Neurocritical Care · Perelman School of Medicine at the University of Pennsylvania
- Present
Department of Hematology and Oncology Section · Perelman School of Medicine at the University of Pennsylvania
PresentPenn Brain Tumor Center · University of Pennsylvania Health System
Research
Lung Cancer · 2017 · First of 19 authors · Corresponding · 433 citations
Nature Medicine · 2024 · Co-first of 33 authors · Corresponding · 336 citations
Clinical Cancer Research · 2016 · 277 citations
42 papers
41 papers
34 papers
19 papers
19 papers
12 papers
- PW
11 papers
10 papers
Clinical trials
- 2025–2042
Different Approaches for CART-EGFR-IL13Ra2 Dosing in Recurrent GBM
Principal investigator · Active not recruiting · Phase 1
University of Pennsylvania
- 2025–2042
CART-EGFR-IL13Ra2 in Newly Diagnosed GBM Following Initial Radiotherapy
Principal investigator · Active not recruiting · Phase 1
University of Pennsylvania
- 2023–2039
CART-EGFR-IL13Ra2 in EGFR Amplified Recurrent GBM
Principal investigator · Active not recruiting · Phase 1
University of Pennsylvania
- 2022–2028
All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma
Principal investigator · Recruiting · Phase 2
Stephen Bagley, MD, MSCE